Form 4 for IOVA IOVANCE BIOTHERAPEUTICS, INC.
Accepted 2026-02-26 00:00:00 ET · period of report 2026-02-24 · accession 0001104659-26-020613 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-26 | 2026-02-24 | IOVA | Kirby Daniel Gordon | Chief Commercial Off | M - OptEx | $0.00 | +120.0K | 173.5K | +224% | $0 |
| D | 2026-02-26 | 2026-02-24 | IOVA | Kirby Daniel Gordon | Chief Commercial Off | F - Tax | $3.78 | -34.2K | 139.4K | -20% | -$129.1K |
| D | 2026-02-26 | 2026-02-24 | IOVA | Kirby Daniel Gordon | Chief Commercial Off | M - OptEx | $0.00 | -150.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-24 | M | A | 120,000 | $0.00 | 173,546 | D | — | — | (F1) Represents the number of shares of the Issuer's common stock underlying performance-based restricted stock units ("PSUs") that have been earned based on the level of achievement of certain financial milestones. The earned PSUs vested on February 24, 2026. |
| 2 | Common | Common Stock | 2026-02-24 | F | D | 34,165 | $3.78 | 139,381 | D | — | — | (F2) Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the PSUs. This is not an open market sale of securities. (F3) Represents the common stock remaining after deducting the common stock withheld for taxes. |
| 3 | Derivative | Restricted Stock Units | 2026-02-24 | M | D | 150,000 | $0.00 | 0 | D | — · — to — | 150,000 Common Stock | (F4) Each PSU represents a contingent right to receive one share of the Issuer's common stock. (F5) On February 10, 2025, the Reporting Person was granted an award of up to 150,000 PSUs, which vests in the form of shares of the Issuer's common stock upon the achievement of certain financial milestones. On February 24, 2026, certain financial milestones were met, resulting in the vesting of the PSUs as to 120,000 of the underlying shares and the cancellation of the PSUs as to 30,000 of the underlying shares. |